Literature DB >> 31794944

A framework for modeling radiation induced lymphopenia in radiotherapy.

Jian-Yue Jin1, Todd Mereniuk2, Anirudh Yalamanchali2, Weili Wang3, Mitchell Machtay3, Feng-Ming Spring Kong3, Susannah Ellsworth2.   

Abstract

INTRODUCTION: Associations between radiation-induced lymphopenia (RIL) and survival have been extensively reported. However, the immune system is not considered as an organ-at-risk (OAR) in radiotherapy. This study aimed to develop the framework of an immune OAR model that may be utilized to predict and minimize RIL.
METHODS: A dynamic model was first developed for lymphocyte trafficking among 5 compartments of the immune system. Radiation dose to the circulating lymphocytes in each compartment was calculated based on the doses to fixed structures of each immune compartment and blood flow patterns. A RIL model was developed based on lymphocyte dynamics, lymphocyte radiosensitivity and reproductivity, and the dose to the lymphocytes. The model was tested in 51 patients by fitting it to weekly-measured absolute lymphocyte counts (ALC) for each patient, considering lymphocyte radiosensitivity and reproductivity as patient-dependent fitting parameters.
RESULTS: The fitting was almost perfect for 20 patients, with sum of square of errors (SSE) between measured and predicted ALCs < 0.5. It was acceptable for another 27 patients, with SSE = 0.5~4.0. Only 4 patients had SSE > 4.0. The fitting also provided a method of in vivo estimation of radiosensitivity (α) for each patient. The median α was 0.40 Gy-1 for the 51 patients, consistent with in vitro measured data of 0.41 Gy-1 in the literature.
CONCLUSION: We have presented a framework of developing an immune OAR model that has the potential to predict and minimize RIL in radiotherapy.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Immune organ at risk; Immune system; Lymphopenia; Radiation dose to the blood; Radiosensitivity

Mesh:

Year:  2019        PMID: 31794944     DOI: 10.1016/j.radonc.2019.11.014

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  11 in total

1.  Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?

Authors:  Jian-Yue Jin; Anxin Gu; Weili Wang; Nancy L Oleinick; Mitchell Machtay; Feng-Ming Spring Kong
Journal:  Radiother Oncol       Date:  2020-05-06       Impact factor: 6.280

2.  Potential Determinants for Radiation-Induced Lymphopenia in Patients With Breast Cancer Using Interpretable Machine Learning Approach.

Authors:  Hao Yu; Fang Chen; Ka-On Lam; Li Yang; Yang Wang; Jian-Yue Jin; Aya Ei Helali; Feng-Ming Spring Kong
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

3.  Mathematical Modeling to Simulate the Effect of Adding Radiation Therapy to Immunotherapy and Application to Hepatocellular Carcinoma.

Authors:  Wonmo Sung; Theodore S Hong; Mark C Poznansky; Harald Paganetti; Clemens Grassberger
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-11-11       Impact factor: 8.013

4.  Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer.

Authors:  Fang Chen; Jian-Yue Jin; Timothy S K Hui; Haiman Jing; Hong Zhang; Yaqing Nong; Ying Han; Weili Wang; Lingyu Ma; Fan Yi; Qingqing Chen; Yongsheng Zhang; Pingfu Fu; Li Yang; Zhiyuan Xu; Feng-Ming Spring Kong
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

5.  A dynamic blood flow model to compute absorbed dose to circulating blood and lymphocytes in liver external beam radiotherapy.

Authors:  Shu Xing; Jungwook Shin; Jennifer Pursley; Camilo M Correa-Alfonso; Nicolas Depauw; Sean Domal; Julia Withrow; Wesley Bolch; Clemens Grassberger; Harald Paganetti
Journal:  Phys Med Biol       Date:  2022-02-15       Impact factor: 3.609

6.  HEDOS-a computational tool to assess radiation dose to circulating blood cells during external beam radiotherapy based on whole-body blood flow simulations.

Authors:  Jungwook Shin; Shu Xing; Lucas McCullum; Abdelkhalek Hammi; Jennifer Pursley; Camilo A Correa; Julia Withrow; Sean Domal; Wesley Bolch; Harald Paganetti; Clemens Grassberger
Journal:  Phys Med Biol       Date:  2021-08-03       Impact factor: 4.174

7.  Chronological Analysis of Acute Hematological Outcomes after Proton and Photon Beam Craniospinal Irradiation in Pediatric Brain Tumors.

Authors:  Gyu Sang Yoo; Jeong Il Yu; Sungkoo Cho; Youngyih Han; Yoonjin Oh; Do Hoon Lim; Hee Rim Nam; Ji-Won Lee; Ki-Woong Sung; Hyung Jin Shin
Journal:  Cancer Res Treat       Date:  2021-10-15       Impact factor: 5.036

8.  Radiation-Induced Lymphopenia Risks of Photon Versus Proton Therapy for Esophageal Cancer Patients.

Authors:  Saba Ebrahimi; Gino Lim; Amy Liu; Steven H Lin; Susannah G Ellsworth; Clemens Grassberger; Radhe Mohan; Wenhua Cao
Journal:  Int J Part Ther       Date:  2021-04-07

9.  Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapy.

Authors:  Fang Chen; Hao Yu; Hong Zhang; Yaqing Nong; Qian Wang; Haiman Jing; Ying Han; Junjie Wu; Zheng Zhou; Li Yang; Zhiyuan Xu; Yaya Liu; Pingfu Fu; Jian-Yue Jin; Victor Hsue; Amy Chang; Feng-Ming Spring Kong
Journal:  Ann Transl Med       Date:  2021-08

10.  Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer.

Authors:  Elgin Hoffmann; Frank Paulsen; Philipp Schaedle; Daniel Zips; Cihan Gani; Hans-Georg Rammensee; Cécile Gouttefangeas; Franziska Eckert
Journal:  Cancer Immunol Immunother       Date:  2021-07-16       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.